Backtested Scanners
Joel Greenblatt: Magic Formula
Read the study: The Magic Formula, Retested: 14.48% a Year Since 2000 — Behind the Market Since 2010
32 Hits · last calculated November 2, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 31 hits from US
Methodology & criteria
The simplified screener version of Greenblatt's "The Little Book That Beats the Market": above-average companies (return on capital ≥ 25%, approximated as ROE × equity ratio) at below-average prices (positive P/E, at least 5 to filter out data outliers). Financials and utilities are excluded as in the original, minimum market cap $50 million. We back-tested the formula for you from late 1999 to July 2026: the full original ranking of earnings yield and return on capital returned 14.48% a year against 8.28% for the S&P 500 — the screener version this scanner implements came in at 10.07% a year. Honest caveat: since 2010 the formula has trailed the S&P 500 by roughly 3.8 percentage points a year on average. Source: fundamental data.
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
🔔 Watch scanner
Hit List
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Volatility | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Bankruptcy Check | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MU Micron Technology Inc | — | +511 % | 81 % | Stage 2 | A 89 | 6 of 9 | 1,149.3 $ | Semiconductors | Sells AI | — | 0/3 | Technology | 884.70 $ | +268.7 % | +299.8 % | +295.4 % | −3.3 % | +76.5 % | 99 | 96 | 10.6 % | 9.5 % | 2.23 | 18.4 | 5.1 | 8.6 | 9.1 | 16.2 | 0.16 | 8.8 | 80.4 % | 80.7 % | 63.8 % | 39.8 % | 44.6 % | 0.06 | 75.1 % | +48.9 % | 9 | 0.1 % | 0.8 % | 11.7 | 81.6 % | 2.0 % | 4.6 (49) | |
| SNDK Sandisk Corp | 08/13 | — | ⚠ Wildest 10% 112 % | Stage 2 | A 91 | 7 of 9 | 197.4 $ | Computer Hardware | Sells AI | — | 0/3 | Technology | 1,150.90 $ | +727.2 % | +719.9 % | +487.7 % | −0.8 % | +82.9 % | 99 | 96 | 10.9 % | 9.6 % | — | 39.4 | 5.9 | 6.8 | 12.4 | 11.4 | — | 14.2 | 70.0 % | 71.5 % | 56.5 % | 39.3 % | 43.9 % | 0.02 | 80.7 % | +10.4 % | 9 | 0.0 % | 0.0 % | 13.0 | 80.8 % | 3.3 % | 4.5 (25) | |
| WDC Western Digital Corporation | 07/29 | +752 % | 80 % | Stage 2 | A 84 | 6 of 9 | 137.8 $ | Computer Hardware | Uses AI | — | 0/3 | Technology | 366.10 $ | +289.6 % | +263.3 % | +165.5 % | −15.6 % | +67.5 % | 99 | 95 | 11.5 % | 8.3 % | 2.17 | 18.6 | 16.3 | 9.5 | 11.1 | 32.1 | 0.57 | 13.3 | 37.0 % | 52.6 % | 69.2 % | 85.9 % | 25.9 % | 0.32 | 64.3 % | +50.7 % | 7 | 0.2 % | 4.2 % | 10.8 | 101.2 % | 5.2 % | 4.5 (26) | |
| LRCX Lam Research Corp | 07/29 | +176 % | 66 % | Stage 2 | A 77 | 8 of 9 | 329.8 $ | Semiconductor Equipment & Materials | Uses AI | — | 0/3 | Technology | 239.10 $ | +117.3 % | +132.2 % | +49.2 % | −1.9 % | +52.3 % | 96 | 75 | 7.4 % | 6.9 % | 1.85 | 42.2 | 26.4 | 12.6 | 26.4 | 44.4 | 1.11 | 30.5 | 35.0 % | 51.1 % | 32.3 % | 66.8 % | 25.0 % | 0.35 | 50.9 % | +23.7 % | 8 | 0.6 % | 16.4 % | 14.5 | 88.1 % | 2.3 % | 4.6 (34) | |
| CRDO Credo Technology Group Holding Ltd | 09/02 | +487 % | ⚠ Wildest 10% 96 % | Stage 2 | A 85 | 7 of 9 | 28.1 $ | Semiconductors | Sells AI | — | 0/3 | Technology | 151.00 $ | +89.0 % | +63.6 % | -9.4 % | −13.2 % | +69.7 % | 96 | 93 | 10.5 % | 11.3 % | 3.25 | 54.2 | 23.5 | 17.7 | 12.1 | 64.0 | — | 48.6 | 35.7 % | 67.1 % | 33.8 % | 34.4 % | 16.1 % | 0.01 | 89.9 % | +205.7 % | 9 | 0.0 % | 0.0 % | 19.7 | 75.9 % | 6.7 % | 4.7 (20) | |
| KLAC KLA Corporation | 07/30 | +150 % | 62 % | Stage 2 | B 68 | 6 of 9 | 206.3 $ | Semiconductor Equipment & Materials | Uses AI | — | 0/3 | Technology | 157.90 $ | +101.7 % | +118.6 % | +30.7 % | −89.4 % | +40.2 % | 94 | 60 | 7.6 % | 6.9 % | 1.45 | 42.5 | 29.2 | 14.2 | 35.0 | 51.1 | 1.51 | 30.5 | 41.2 % | 61.5 % | 36.3 % | 95.0 % | 22.3 % | 1.52 | 34.6 % | +23.9 % | 6 | 0.6 % | 20.5 % | 9.6 | 93.8 % | 1.9 % | 4.2 (29) | |
| TGTX TG Therapeutics Inc | 08/03 | +43 % | 45 % | Stage 2 | B 65 | 5 of 9 | 9.5 $ | Biotechnology | Neutral | — | 0/3 | Healthcare | 61.20 $ | +80.9 % | +79.3 % | +71.9 % | −6.5 % | +21.5 % | 90 | 92 | 5.0 % | 4.8 % | 1.80 | 22.5 | 25.4 | 11.8 | 16.9 | 540.1 | 1.61 | 61.6 | 17.0 % | 82.4 % | 55.2 % | 112.6 % | 7.3 % | 1.29 | 38.1 % | +87.3 % | 6 | 0.0 % | 0.0 % | 6.2 | 70.2 % | 28.9 % | 4.5 (8) | |
| MSGE Madison Square Garden Entertainment Corp. | 08/12 | +45 % | 30 % | Stage 2 | B 61 | 6 of 9 | 3.7 $ | Entertainment | Neutral | — | 0/3 | Communication Services | 80.40 $ | +41.8 % | +48.6 % | +83.0 % | −0.6 % | +14.1 % | 86 | 18 | 4.0 % | 3.0 % | 0.56 | 77.4 | 26.2 | 3.3 | 82.4 | 11.0 | — | 22.2 | 10.3 % | 47.3 % | 6.2 % | 170.3 % | 5.8 % | 0.08 | 53.2 % | -1.7 % | 3 | 0.0 % | 0.0 % | 4.1 | 102.1 % | 4.6 % | 3.8 (10) | |
| DUOT Duos Technologies Group Inc | 08/13 | +27 % | 82 % | Stage 2 | B 63 | 4 of 9 | 0.2 $ | Software - Application | Sells AI | — | 0/3 | Technology | 6.20 $ | -44.9 % | -31.3 % | -35.3 % | −57.7 % | +204.2 % | 86 | 42 | 9.9 % | 11.0 % | 1.36 | 5.2 | 9.7 | 6.8 | 0.9 | — | — | 1.6 | 0.8 % | 35.1 % | 150.5 % | 36.0 % | -5.0 % | 0.02 | 76.6 % | +271.2 % | 6 | 0.0 % | 0.0 % | 6.2 | 59.2 % | 25.7 % | 4.3 (3) | |
| AUPH Aurinia Pharmaceuticals Inc | 07/30 | +31 % | 37 % | Stage 2 | B 72 | 6 of 9 | 2.1 $ | Biotechnology | Neutral | — | 0/3 | Healthcare | 16.70 $ | +12.1 % | +3.2 % | +40.8 % | −8.8 % | +3.4 % | 83 | 79 | 5.6 % | 4.2 % | 1.61 | 7.8 | 11.8 | 6.5 | 3.8 | 11.9 | — | 10.3 | 53.3 % | 77.9 % | 100.8 % | 65.0 % | 15.5 % | 0.12 | 78.4 % | +20.4 % | 7 | 0.0 % | 0.0 % | 9.2 | 60.3 % | 6.5 % | 4.4 (7) | |
| GOOGL Alphabet Inc Class A | 07/22 | +62 % | 34 % | Stage 2 | B 67 | 6 of 9 | 3,414.3 $ | Internet Content & Information | Sells AI | — | 0/3 | Communication Services | 279.80 $ | +10.7 % | +12.7 % | -0.3 % | −15.9 % | +45.3 % | 79 | 83 | 3.8 % | 3.1 % | 1.21 | 21.4 | 17.9 | 7.2 | 7.3 | 172.9 | 0.98 | 10.4 | 36.1 % | 60.9 % | 50.0 % | 38.9 % | 12.7 % | 0.22 | 68.0 % | +15.1 % | 7 | 0.3 % | 4.5 % | 10.1 | 80.8 % | 1.3 % | 4.6 (58) | |
| GOOG Alphabet Inc Class C | 07/22 | +61 % | 33 % | Stage 2 | B 67 | 6 of 9 | 3,421.2 $ | Internet Content & Information | Sells AI | — | — | 0/3 | Communication Services | 278.20 $ | +10.4 % | +11.4 % | -1.1 % | −15.4 % | +45.2 % | 79 | 83 | 3.6 % | 3.1 % | 1.21 | 21.2 | 18.1 | 7.3 | 7.1 | 173.3 | 0.99 | 17.9 | 36.1 % | 60.9 % | 50.0 % | 38.9 % | 12.7 % | 0.22 | 68.0 % | +15.1 % | 7 | 0.3 % | 4.5 % | 10.1 | 61.1 % | 0.3 % | 4.6 (60) |
| LLY Eli Lilly and Company | 08/06 | +49 % | 35 % | Stage 2 | A 75 | 8 of 9 | 1,264.0 $ | Drug Manufacturers - General | Uses AI | — | 0/3 | Healthcare | 1,417.50 $ | +3.4 % | +14.6 % | +68.9 % | −4.7 % | -1.4 % | 72 | 89 | 3.1 % | 3.3 % | 0.45 | 55.1 | 29.7 | 14.6 | 41.4 | 49.0 | 1.36 | 28.1 | 49.4 % | 83.6 % | 31.9 % | 107.5 % | 20.4 % | 1.73 | 26.8 % | +44.7 % | 8 | 0.5 % | 21.7 % | 7.3 | 85.4 % | 0.8 % | 4.4 (31) | |
| EXEL Exelixis Inc | 07/27 | +53 % | 34 % | Stage 2 | B 67 | 8 of 9 | 17.4 $ | Biotechnology | Neutral | — | 0/3 | Healthcare | 69.40 $ | +17.1 % | +16.7 % | +67.9 % | −1.3 % | -15.1 % | 69 | 76 | 3.3 % | 3.1 % | 0.47 | 23.9 | 15.2 | 7.0 | 9.1 | 15.0 | 2.27 | 15.2 | 41.2 % | 96.5 % | 35.3 % | 41.0 % | 24.0 % | 0.09 | 74.6 % | +7.0 % | 8 | 0.0 % | 0.0 % | 10.7 | 107.5 % | 15.6 % | 3.7 (18) | |
| KEX Kirby Corporation | 07/30 | +30 % | 27 % | Stage 2 | B 57 | 6 of 9 | 7.7 $ | Marine Shipping | Neutral | — | 0/3 | Industrials | 143.90 $ | +25.5 % | +24.0 % | +44.6 % | −12.1 % | +15.7 % | 68 | 60 | 2.2 % | 2.4 % | 0.84 | 21.6 | 15.9 | 2.2 | 2.2 | 14.1 | 2.63 | 10.5 | 13.3 % | 33.2 % | 10.2 % | 10.7 % | 5.1 % | — | 5,889.4 % | +3.0 % | 5 | 0.0 % | 0.0 % | — | 103.0 % | 5.2 % | 4.9 (7) | |
| AAPL Apple Inc | 07/30 | +20 % | 24 % | Stage 2 | B 68 | 8 of 9 | 5,061.3 $ | Consumer Electronics | Uses AI | — | 0/3 | Technology | 344.60 $ | +8.5 % | +3.1 % | +27.5 % | −13.3 % | -3.5 % | 65 | 67 | 2.9 % | 2.5 % | 1.07 | 42.3 | 36.4 | 10.8 | 46.7 | 37.0 | 2.80 | 30.4 | 32.3 % | 48.7 % | 27.6 % | 141.5 % | 27.1 % | 0.80 | 28.7 % | +6.4 % | 6 | 0.3 % | 15.4 % | 6.6 | 65.8 % | 0.9 % | 3.8 (43) | |
| NVDA NVIDIA Corporation | 08/26 | +125 % | 37 % | Stage 2 | A 84 | 7 of 9 | 5,168.9 $ | Semiconductors | Sells AI | — | 0/3 | Technology | 204.60 $ | +7.4 % | +3.5 % | +1.1 % | −17.3 % | +60.8 % | 62 | 91 | 3.2 % | 3.6 % | 2.22 | 27.6 | 13.5 | 17.1 | 22.4 | 39.9 | 0.26 | 22.0 | 65.6 % | 74.7 % | 63.7 % | 114.3 % | 53.6 % | 0.07 | 75.3 % | +65.5 % | 8 | 0.5 % | 7.4 % | 16.4 | 70.9 % | 1.3 % | 4.7 (62) | |
| FAST Fastenal Company | 07/14 | +24 % | 24 % | Stage 2 | B 63 | 8 of 9 | 59.9 $ | Industrial Distribution | – | — | — | 0/3 | Industrials | 51.90 $ | +14.9 % | +14.6 % | +27.6 % | −7.3 % | -1.0 % | 41 | 61 | 2.4 % | 2.2 % | 0.69 | 45.7 | 37.5 | 6.6 | 14.8 | 50.9 | 3.39 | 29.5 | 20.3 % | 44.6 % | 15.6 % | 33.8 % | 22.0 % | 0.11 | 76.6 % | +8.7 % | 6 | 2.0 % | 65.4 % | 14.9 | 88.2 % | 3.4 % | 3.3 (18) |
| DECK Deckers Outdoor Corporation | 07/23 | +8 % | 41 % | Stage 1 | B 55 | 4 of 9 | 11.4 $ | Footwear & Accessories | Uses AI | — | 0/3 | Consumer Cyclical | 82.00 $ | +0.0 % | +0.3 % | -1.3 % | −18.9 % | +22.0 % | 34 | 29 | 4.1 % | 3.9 % | 1.12 | 12.6 | 10.8 | 2.0 | 4.8 | 10.0 | 0.99 | 7.7 | 14.0 % | 58.9 % | 19.0 % | 40.9 % | 21.3 % | 0.15 | 67.8 % | +9.4 % | 6 | 0.0 % | 0.0 % | 13.5 | 100.8 % | 9.7 % | 3.5 (27) | |
| TPL Texas Pacific Land Corporation | 08/05 | +58 % | 49 % | Stage 1 | B 72 | 4 of 9 | 22.3 $ | Oil & Gas E&P | – | — | — | 0/3 | Energy | 331.70 $ | +29.1 % | +42.3 % | +7.8 % | −64.0 % | +34.1 % | 33 | 64 | 4.4 % | 4.4 % | 0.59 | 45.3 | 37.7 | 24.9 | 14.6 | 40.7 | 7.33 | 30.6 | 77.2 % | 93.3 % | 60.3 % | 36.5 % | 25.8 % | 0.01 | 88.8 % | +13.1 % | 7 | 0.7 % | 20.5 % | 18.4 | 74.9 % | 7.2 % | 3.0 (2) |
| ACAD ACADIA Pharmaceuticals Inc | 08/05 | -3 % | 39 % | Stage 1 | B 58 | 5 of 9 | 3.5 $ | Biotechnology | Uses AI | — | 0/3 | Healthcare | 20.60 $ | -15.4 % | -9.6 % | -7.9 % | −16.3 % | +50.4 % | 32 | 6 | 4.6 % | 3.5 % | 0.89 | 10.0 | 19.5 | 3.0 | 3.0 | 23.7 | 50.86 | 25.6 | -1.7 % | 62.1 % | 33.4 % | 37.3 % | 3.6 % | 0.04 | 77.8 % | +11.9 % | 6 | 0.0 % | 0.0 % | 7.0 | 99.1 % | 7.6 % | 4.1 (20) | |
| APP Applovin Corp | 08/05 | +632 % | 74 % | Stage 4 | A 79 | 9 of 9 | 77.2 $ | Advertising Agencies | – | — | — | 0/3 | Communication Services | 228.50 $ | -30.7 % | -31.4 % | -63.2 % | −40.2 % | +96.3 % | 31 | 87 | 6.5 % | 6.6 % | 2.56 | 20.8 | 11.2 | 11.3 | 34.0 | 17.1 | 0.50 | 13.9 | 78.1 % | 88.5 % | 64.6 % | 266.4 % | 46.5 % | 4.18 | 30.7 % | +70.0 % | 10 | 0.0 % | 0.0 % | 11.6 | 75.0 % | 3.8 % | 4.4 (33) |
| IDXX IDEXX Laboratories Inc | 08/03 | +4 % | 32 % | Stage 4 | B 67 | 7 of 9 | 43.8 $ | Diagnostics & Research | – | — | — | 0/3 | Healthcare | 551.20 $ | -20.0 % | -22.1 % | -12.3 % | −27.9 % | +24.4 % | 23 | 63 | 3.3 % | 3.0 % | 1.55 | 41.3 | 33.8 | 9.6 | 28.4 | 35.1 | 3.07 | 27.9 | 31.8 % | 62.5 % | 25.0 % | 72.9 % | 27.1 % | 0.97 | 46.0 % | +10.4 % | 6 | 0.0 % | 0.0 % | 13.7 | 96.2 % | 2.8 % | 3.9 (14) |
| MANH Manhattan Associates Inc | 07/28 | -10 % | 46 % | Stage 4 | C 53 | 5 of 9 | 14.5 $ | Software - Application | – | — | — | 0/3 | Technology | 248.40 $ | -24.9 % | -21.2 % | +35.1 % | −48.3 % | +0.8 % | 13 | 30 | 4.8 % | 4.7 % | 0.95 | 71.3 | 40.3 | 12.6 | 73.4 | 38.3 | 2.57 | 47.6 | 23.0 % | 55.8 % | 18.7 % | 96.2 % | 24.5 % | 0.39 | 27.7 % | +3.8 % | 6 | 0.0 % | 0.0 % | 7.8 | 113.3 % | 7.1 % | 4.4 (11) |
| PLTR Palantir Technologies Inc. | 08/03 | +244 % | 59 % | Stage 4 | A 84 | 8 of 9 | 451.9 $ | Software - Infrastructure | Sells AI | — | — | 0/3 | Technology | 184.10 $ | -34.3 % | -40.4 % | -5.4 % | −48.3 % | +15.4 % | 10 | 93 | 5.3 % | 4.9 % | 1.60 | 198.6 | 87.7 | 73.4 | 50.1 | 134.5 | 1.70 | 173.8 | 46.2 % | 84.8 % | 49.0 % | 32.6 % | 17.3 % | 0.03 | 82.9 % | +56.2 % | 8 | 0.0 % | 0.0 % | 14.6 | 62.4 % | 2.6 % | 4.1 (32) |
| ADMA ADMA Biologics Inc | 08/05 | +42 % | 56 % | Stage 4 | B 65 | 7 of 9 | 2.6 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 11.40 $ | -52.4 % | -57.2 % | -24.3 % | −57.4 % | +50.4 % | 4 | 14 | 4.2 % | 4.0 % | 0.69 | 17.3 | 11.3 | 5.2 | 7.0 | 22.7 | — | 11.0 | -123.4 % | 64.7 % | 33.0 % | 43.3 % | 21.8 % | 0.52 | 58.7 % | +19.6 % | 6 | 0.0 % | 0.0 % | 10.6 | 94.0 % | 10.7 % | 4.3 (4) |
| DMLP Dorchester Minerals LP | — | — | 23 % | — | A 77 | 4 of 9 | 1.5 $ | Oil & Gas E&P | – | — | — | 0/3 | Energy | 29.80 $ | +21.6 % | +9.1 % | +34.1 % | −5.6 % | — | — | — | — | — | 0.61 | 17.0 | 20.8 | 7.6 | 4.7 | 9.4 | 0.83 | 8.7 | 55.1 % | 92.9 % | 45.3 % | 28.0 % | 17.1 % | 0.00 | 100.2 % | -5.4 % | 6 | 10.7 % | 2.2 % | — | 26.3 % | 1.0 % | — |
| SBR Sabine Royalty Trust | — | — | 23 % | — | C 54 | 5 of 9 | 1.0 $ | Oil & Gas Midstream | – | — | — | 0/3 | Energy | 70.90 $ | +5.9 % | +4.1 % | +5.9 % | −11.5 % | -54.2 % | — | — | — | — | 0.29 | 14.5 | 10.4 | 13.8 | 123.2 | — | 1.35 | 14.4 | 91.4 % | 100.0 % | 94.7 % | 83.3 % | 507.1 % | 0.00 | 89.6 % | -6.7 % | 6 | 6.0 % | 54.3 % | — | 18.8 % | 0.1 % | — |
| NNNN Anbio Biotechnology | — | — | ⚠ Wildest 10% 134 % | — | B 68 | 4 of 9 | 0.1 $ | Medical Instruments & Supplies | – | — | — | 0/3 | Healthcare | 3.40 $ | -65.6 % | -55.5 % | -83.9 % | −80.1 % | — | — | — | — | — | — | 22.6 | 0.0 | — | 4.8 | — | — | 40.4 | 59.1 % | 87.2 % | 74.1 % | 27.1 % | 14.7 % | 0.00 | 99.7 % | +5.6 % | 5 | 0.0 % | 0.0 % | — | 4.9 % | 0.1 % | — |
| MSB Mesabi Trust | — | — | 45 % | — | D 34 | 5 of 9 | 0.2 $ | Steel | – | — | — | 0/3 | Basic Materials | 17.70 $ | -38.8 % | -34.1 % | -48.3 % | −42.7 % | +81.3 % | — | — | — | — | 0.33 | 20.6 | 12.8 | 19.3 | 12.5 | 0.0 | — | 32.9 | 48.4 % | 100.0 % | 54.5 % | 59.7 % | 18.4 % | 0.00 | 83.8 % | -31.2 % | 7 | 4.9 % | 1.8 % | 51.1 | 54.4 % | 1.0 % | — |
| CGEN Compugen | — | — | 63 % | — | B 55 | 6 of 9 | 0.2 $ | Biotechnology | – | — | — | 0/3 | Healthcare | 2.00 $ | +56.9 % | +40.4 % | +20.0 % | −22.6 % | +142.1 % | — | — | — | — | 2.79 | 5.1 | 12.4 | 2.6 | 2.1 | — | 1.29 | 3.5 | -339.6 % | 86.9 % | 47.6 % | 50.6 % | 15.5 % | 0.01 | 65.5 % | +161.1 % | 7 | 0.0 % | 0.0 % | 0.6 | 15.3 % | 2.5 % | 5.0 (5) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
The simplified screener version of Greenblatt's "The Little Book That Beats the Market": above-average companies (return on capital ≥ 25%, approximated as ROE × equity ratio) at below-average prices (positive P/E, at least 5 to filter out data outliers). Financials and utilities are excluded as in the original, minimum market cap $50 million.
All scanners are recalculated daily across the entire stock universe — most recently on November 2, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 32 stocks pass this scanner's criteria (as of November 2, 2026).
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
Related scanners
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.